IRulya Therapeutics (IRLA) Other Accumulated Expenses (2018 - 2026)
IRulya Therapeutics (IRLA) posted Other Accumulated Expenses of $722,000 for Q2 2026, down 71.5% from $2.53 million a year earlier and down 58.8% from the prior quarter.
Powered by 
Analysis
IRulya Therapeutics (IRLA) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, IRulya Therapeutics' Other Accumulated Expenses came in at $6.97 million, up 577.0% from FY2024.
- Annual Other Accumulated Expenses has increased for three consecutive years, though with a five-year compound annual growth rate of -8.1% (FY2020 to FY2025).
- In prior years, IRulya Therapeutics' Other Accumulated Expenses was $1.03 million in FY2024 (+82.4%), $564,000 in FY2023 (+13.5%), $497,000 in FY2022 (-93.0%) and $7.11 million in FY2021 (-33.0%).
- The Q2 2026 figure stands as the lowest quarterly Other Accumulated Expenses since Q4 2023.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q4 2025, with growth of 577.0%; the weakest was Q1 2023, with a decline of 98.4%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $1.75 million (Q1 2026), $6.97 million (Q4 2025) and $2.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | IRulya Therapeutics | 207.35 Mn | 91.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 722,000.00 |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 6.97 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.53 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Mar 31, 2024 | 857,000.00 |
| Dec 31, 2023 | 564,000.00 |
| Sep 30, 2023 | 151,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 497,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 182,000.00 |
| Mar 31, 2022 | 3.49 Mn |
| Dec 31, 2021 | 7.11 Mn |
| Sep 30, 2021 | 7.25 Mn |
| Jun 30, 2021 | 8.37 Mn |
| Mar 31, 2021 | 13.23 Mn |
| Dec 31, 2020 | 10.60 Mn |
API Access
IRulya Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IRLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IRLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IRLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();